Cancer kills through metastasis, yet we still cannot reliably predict which patients will develop it or trace metastatic disease back to its origin. As part of the BMFTR-funded DECIPHER-M consortium (9 partners, €9M), we are building multimodal foundation models that integrate imaging, text, and structured clinical data to predict metastasis risk and identify tumor origin in cancers of unknown primary (CUP).
Disclaimer :
We aim to provide correct and reliable information about
upcoming events, but cannot accept responsibility for the text
of announcements or for the bona fides of event organizers.
Please feel free to contact us if you notice incorrect or
misleading information and we will attempt to correct it.